SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from ISOLAGEN INC (CIK 0000357097) — May 2, 2005

ISOLAGEN INC (CIK 0000357097)
Date: May 2, 2005 · CIK: 0000357097 · Accession: 0001047469-05-012575

AI Filing Summary & Sentiment

File numbers found in text: 333-122440

Date
May 2, 2005
Author
/s/ Martin E. Schmieg
Form
CORRESP
Company
ISOLAGEN INC (CIK 0000357097)

Letter

Re:Isolagen, Inc. Registration Statement on Form S-3 (File No. 333-122440)

[ISOLAGEN, INC. LETTERHEAD]

May 2, 2005

Securities and Exchange Commission

450 Fifth Street, N.W.

Washington, DC 20549

Attn: Albert Lee, Esq

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended (the "Securities Act"), Isolagen, Inc. (the "Company"), respectfully requests that the effective date of its Registration Statement on Form S-3 (File No. 333-122440) ("Registration Statement") be accelerated and that such Registration Statement become effective at 10:00 a.m., Washington, D.C. time, on May 2, 2005, or as soon thereafter as practicable.

Furthermore, please be advised of the following:

The Company acknowledges that the disclosure in the Registration Statement is the responsibility of the Company. The Company further acknowledges that staff comment or changes in response to staff comment in the proposed disclosure in the Registration Statement may not be asserted as a defense in any proceeding which may be brought by any person with respect to this matter. The Company also represents to the Commission that should the Commission or the staff acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing and the Company represents that it will not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

The Company further acknowledges, that the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosures in the filing.

Very truly yours,
/s/ Martin E. Schmieg

Show Raw Text
CORRESP
1
filename1.htm

[ISOLAGEN, INC. LETTERHEAD]

May 2, 2005

Securities
and Exchange Commission

450 Fifth Street, N.W.

Washington, DC 20549

Attn: Albert Lee, Esq

Re:Isolagen, Inc.
Registration Statement on Form S-3 (File No. 333-122440)

Ladies
and Gentlemen:

        Pursuant
to Rule 461 of the Securities Act of 1933, as amended (the "Securities Act"), Isolagen, Inc. (the "Company"), respectfully requests that the effective date of its
Registration Statement on Form S-3 (File No. 333-122440) ("Registration Statement") be accelerated and that such Registration Statement become effective at
10:00 a.m., Washington, D.C. time, on May 2, 2005, or as soon thereafter as practicable.

        Furthermore,
please be advised of the following:

        The
Company acknowledges that the disclosure in the Registration Statement is the responsibility of the Company. The Company further acknowledges that staff comment or changes in
response to staff comment in the proposed disclosure in the Registration Statement may not be asserted as a defense in any proceeding which may be brought by any person with respect to this matter.
The Company also represents to the Commission that should the Commission or the staff acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from
taking any action with respect to the filing and the Company represents that it will not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.

        The
Company further acknowledges, that the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective does not
relieve the Company from its full responsibility for the adequacy and accuracy of the disclosures in the filing.

Very truly yours,

/s/ Martin E. Schmieg

Isolagen, Inc.

Martin E. Schmieg, CFO